| IL-4 induces cathepsin protease activity in tumor-associated macrophages to promote cancer growth and invasion V Gocheva, HW Wang, BB Gadea, T Shree, KE Hunter, AL Garfall, ... Genes & development 24 (3), 241-255, 2010 | 864 | 2010 |
| Macrophages and cathepsin proteases blunt chemotherapeutic response in breast cancer T Shree, OC Olson, BT Elie, JC Kester, AL Garfall, K Simpson, ... Genes & development 25 (23), 2465-2479, 2011 | 584 | 2011 |
| Regulation of dopaminergic loss by Fas in a 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine model of Parkinson's disease S Hayley, SJ Crocker, PD Smith, T Shree, V Jackson-Lewis, ... Journal of Neuroscience 24 (8), 2045-2053, 2004 | 138 | 2004 |
| Identification and pre-clinical testing of a reversible cathepsin protease inhibitor reveals anti-tumor efficacy in a pancreatic cancer model BT Elie, V Gocheva, T Shree, SA Dalrymple, LJ Holsinger, JA Joyce Biochimie 92 (11), 1618-1624, 2010 | 67 | 2010 |
| Single-cell analysis can define distinct evolution of tumor sites in follicular lymphoma S Haebe, T Shree, A Sathe, G Day, DK Czerwinski, SM Grimes, HJ Lee, ... Blood, The Journal of the American Society of Hematology 137 (21), 2869-2880, 2021 | 59 | 2021 |
| Interaction of the c-Jun/JNK pathway and cyclin-dependent kinases in death of embryonic cortical neurons evoked by DNA damage MH Ghahremani, E Keramaris, T Shree, Z Xia, RJ Davis, R Flavell, ... Journal of Biological Chemistry 277 (38), 35586-35596, 2002 | 55 | 2002 |
| CD20-Targeted Therapy Ablates De Novo Antibody Response to Vaccination but Spares Preestablished Immunity T Shree, V Shankar, JJK Lohmeyer, DK Czerwinski, JG Schroers-Martin, ... Blood cancer discovery 3 (2), 95-102, 2022 | 41 | 2022 |
| B-cell lymphomas present immunoglobulin neoantigens MS Khodadoust, N Olsson, B Chen, B Sworder, T Shree, CL Liu, L Zhang, ... Blood, The Journal of the American Society of Hematology 133 (8), 878-881, 2019 | 40 | 2019 |
| Intratumoral immunotherapy relies on B and T cell collaboration I Sagiv-Barfi, DK Czerwinski, T Shree, JJK Lohmeyer, R Levy Science immunology 7 (71), eabn5859, 2022 | 21 | 2022 |
| Impaired immune health in survivors of diffuse large B-cell lymphoma T Shree, Q Li, SL Glaser, A Brunson, HT Maecker, RW Haile, R Levy, ... Journal of Clinical Oncology 38 (15), 1664, 2020 | 20 | 2020 |
| PARP14 is a novel target in STAT6 mutant follicular lymphoma M Mentz, W Keay, CD Strobl, M Antoniolli, L Adolph, M Heide, A Lechner, ... Leukemia 36 (9), 2281-2292, 2022 | 14 | 2022 |
| Site to site comparison of follicular lymphoma biopsies by single cell RNA sequencing S Haebe, T Shree, A Sathe, G Day, HJ Lee, DK Czerwinski, S Grimes, H Ji, ... Blood 134, 297, 2019 | 7 | 2019 |
| Can B cell‐deficient patients rely on COVID‐19 vaccine‐induced T‐cell immunity? T Shree British Journal of Haematology 197 (6), 659-661, 2022 | 4 | 2022 |
| Intratumoral CpG, Local Radiation, and Oral Ibrutinib Combine to Produce Effective in Situ Vaccination in Patients with Low-Grade B-Cell Lymphoma T Shree, MS Khodadoust, DK Czerwinski, MJ Frank, S Beygi, SR Long, ... Blood 136, 48, 2020 | 4 | 2020 |
| In situ vaccination with Cpg and anti-OX40 antibody: preclinical optimization for clinical translation IS Barfi, DK Czerwinski, T Shree, R Levy Blood 132, 2943, 2018 | 3 | 2018 |
| Single-cell multi-gene identification of somatic mutations and gene rearrangements in cancer SM Grimes, HS Kim, S Roy, A Sathe, CI Ayala, X Bai, ... NAR cancer 5 (3), zcad034, 2023 | 2 | 2023 |
| Serial FNA allows direct sampling of malignant and infiltrating immune cells in patients with B‐cell lymphoma receiving immunotherapy KL Mooney, DK Czerwinski, T Shree, MJ Frank, S Haebe, BA Martin, ... Cancer Cytopathology 130 (3), 231-237, 2022 | 2 | 2022 |
| A phase I/II trial of intratumoral CpG, local low-dose radiation, and oral ibrutinib in patients with low-grade B-cell lymphoma T Shree, MS Khodadoust, DK Czerwinski, MJ Frank, WX Hong, ... Blood 134, 2825, 2019 | 2 | 2019 |
| IMPAIRED IMMUNE HEALTH IN SURVIVORS OF DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL): A LARGE POPULATION‐BASED STUDY T Shree, Q Li, AM Brunson, S Glaser, HT Maecker, R Haile, R Levy, ... Hematological Oncology 37, 80-81, 2019 | 2 | 2019 |
| Intratumoral injection of CpG-ODN plus systemic ibrutinib induces an anti-tumor immune response affecting T cell subsets in the microenvironment of both injected and non … DK Czerwinski, MJ Frank, T Shree, MS Khodadoust, SR Long, R Levy Blood 132, 1612, 2018 | 2 | 2018 |
Alfred GarfallUniversity of PennsylvaniaVerified email at pennmedicine.upenn.edu
